BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1711186)

  • 1. HMB-45 immunohistochemical staining of conjunctival melanocytic lesions.
    McDonnell JM; Sun YY; Wagner D
    Ophthalmology; 1991 Apr; 98(4):453-8. PubMed ID: 1711186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WT1 and Bcl2 expression in melanocytic lesions of the conjunctiva: an immunohistochemical study of 123 cases.
    Furusato E; Hidayat AA; Man YG; Auerbach A; Furusato B; Rushing EJ
    Arch Ophthalmol; 2009 Aug; 127(8):964-9. PubMed ID: 19667332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential immunoreactivity of melanocytic lesions of the conjunctiva.
    Sharara NA; Alexander RA; Luthert PJ; Hungerford JL; Cree IA
    Histopathology; 2001 Oct; 39(4):426-31. PubMed ID: 11683945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Distribution of melanoma-associated antigens (HMB 45 and S 100) in benign and malignant melanocytic tumors of the conjunctiva].
    Steuhl KP; Rohrbach JM; Knorr M
    Klin Monbl Augenheilkd; 1991 Sep; 199(3):187-91. PubMed ID: 1753671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical studies of atypical conjunctival melanocytic nevi.
    Jakobiec FA; Colby K; Bajart AM; Saragas SJ; Moulin A
    Arch Ophthalmol; 2009 Aug; 127(8):970-80. PubMed ID: 19667333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation.
    Skelton HG; Smith KJ; Barrett TL; Lupton GP; Graham JH
    Am J Dermatopathol; 1991 Dec; 13(6):543-50. PubMed ID: 1725245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical studies of conjunctival nevi and melanomas.
    Jakobiec FA; Bhat P; Colby KA
    Arch Ophthalmol; 2010 Feb; 128(2):174-83. PubMed ID: 20142539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical profiling including beta-catenin in conjunctival melanocytic lesions.
    Reddy HS; Keene CD; Chang SH; Jian-Amadi A; Cimino PJ
    Exp Mol Pathol; 2017 Apr; 102(2):198-202. PubMed ID: 28161440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMB-45 antibody reactivity in pigmented lesions of the conjunctiva.
    Glasgow BJ; McCall LC; Foos RY
    Am J Ophthalmol; 1990 Jun; 109(6):696-700. PubMed ID: 2189315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of melanocytic lesions of the conjunctiva in a review of 10 675 ophthalmic specimens.
    Novais GA; Fernandes BF; Belfort RN; Castiglione E; Cheema DP; Burnier MN
    Int J Surg Pathol; 2010 Feb; 18(1):60-3. PubMed ID: 18611943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine Receptor Expression Pattern Correlates to Progression of Conjunctival Melanocytic Lesions.
    van Ipenburg JA; de Waard NE; Naus NC; Jager MJ; Paridaens D; Verdijk RM
    Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):2950-2957. PubMed ID: 31305861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance, specificity, and ultrastructural localization of HMB-45 antigen in pigmented ocular tumors.
    Steuhl KP; Rohrbach JM; Knorr M; Thiel HJ
    Ophthalmology; 1993 Feb; 100(2):208-15. PubMed ID: 8437829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanocytic lesions of the conjunctiva.
    Zembowicz A; Mandal RV; Choopong P
    Arch Pathol Lab Med; 2010 Dec; 134(12):1785-92. PubMed ID: 21128776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical analysis of benign and malignant melanocytic lesions of the conjunctiva using double-staining.
    Soon AK; Brownstein S; Tang T; Saleh S; Jiang K; Levac J; Blanco P; Farmer J
    Can J Ophthalmol; 2019 Dec; 54(6):699-707. PubMed ID: 31836103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45.
    Heegaard S; Jensen OA; Prause JU
    Melanoma Res; 2000 Aug; 10(4):350-4. PubMed ID: 10985669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo confocal microscopy of pigmented conjunctival tumors.
    Messmer EM; Mackert MJ; Zapp DM; Kampik A
    Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1437-45. PubMed ID: 16598465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctival Primary Acquired Melanosis: Is It Time for a New Terminology?
    Jakobiec FA
    Am J Ophthalmol; 2016 Feb; 162():3-19.e1. PubMed ID: 26556007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16ink4a expression in benign and malignant melanocytic conjunctival lesions.
    Zoroquiain P; Fernandes BF; González S; Novais GN; Schalper KA; Burnier MN
    Int J Surg Pathol; 2012 Jun; 20(3):240-5. PubMed ID: 22287653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of nm23 H-1 protein in conjunctival melanoma and potential precursor lesions.
    Seregard S; Oskarsson M; Spângberg B
    Exp Eye Res; 1999 Dec; 69(6):671-6. PubMed ID: 10620396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Differential diagnosis and management of melanocytic lesions of the ocular surface].
    Tóth G; Szalai E; Csákány B; Hécz R; Sándor GL; Lukáts O; Nagy ZZ; Szentmáry N
    Orv Hetil; 2020 Apr; 161(15):563-574. PubMed ID: 32320191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.